Extended follow-up outcomes of patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab on EMPOWER-CSCC-1: A retrospective cohort study
Journal of the American Academy of Dermatology · 2026
DOI: 10.1016/j.jaad.2025.11.080 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Academy of Dermatology, 2026. Verfasst von Catherine Bennett und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Skin Neoplasms, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Peter MacCallum Cancer Centre, NHMRC.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia; Department of M…
- Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
- The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.
- The University of Queensland, Brisbane, Queensland, Australia; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
Förderung
- Peter MacCallum Cancer Centre
- NHMRC
Zitieren
APA
Bennett, C., McLean, L. S., Lim, A. M., Bressel, M., Guminski, A., Hughes, B. G. M., Bowyer, S. E., Stein, B., & Rischin, D. (2026). Extended follow-up outcomes of patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab on EMPOWER-CSCC-1: A retrospective cohort study. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2025.11.080
Vancouver
Bennett C, McLean LS, Lim AM, Bressel M, Guminski A, Hughes BGM, et al. Extended follow-up outcomes of patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab on EMPOWER-CSCC-1: A retrospective cohort study. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2025.11.080
BibTeX
@article{Bennett2026,
author = {Bennett, Catherine and McLean, Luke S and Lim, Annette M and Bressel, Mathias and Guminski, Alexander and Hughes, Brett G M and Bowyer, Samantha E and Stein, Brian and Rischin, Danny},
title = {Extended follow-up outcomes of patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab on EMPOWER-CSCC-1: A retrospective cohort study},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
doi = {10.1016/j.jaad.2025.11.080}
}
EUVIMED